Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cowpox Virus: A New and Armed Oncolytic Poxvirus.
Ricordel M, Foloppe J, Pichon C, Sfrontato N, Antoine D, Tosch C, Cochin S, Cordier P, Quemeneur E, Camus-Bouclainville C, Bertagnoli S, Erbs P. Ricordel M, et al. Among authors: foloppe j. Mol Ther Oncolytics. 2017 Aug 24;7:1-11. doi: 10.1016/j.omto.2017.08.003. eCollection 2017 Dec 15. Mol Ther Oncolytics. 2017. PMID: 28951885 Free PMC article.
Oncolytic vaccinia virus: a silver bullet?
Lusky M, Erbs P, Foloppe J, Acres RB. Lusky M, et al. Among authors: foloppe j. Expert Rev Vaccines. 2010 Dec;9(12):1353-6. doi: 10.1586/erv.10.137. Expert Rev Vaccines. 2010. PMID: 21105770 Free PMC article. No abstract available.
Oncolytic immunotherapy: The new clinical outbreak.
Fonteneau JF, Achard C, Zaupa C, Foloppe J, Erbs P. Fonteneau JF, et al. Among authors: foloppe j. Oncoimmunology. 2015 Aug 12;5(1):e1066961. doi: 10.1080/2162402X.2015.1066961. eCollection 2016. Oncoimmunology. 2015. PMID: 26942085 Free PMC article. No abstract available.
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment.
Fend L, Remy-Ziller C, Foloppe J, Kempf J, Cochin S, Barraud L, Accart N, Erbs P, Fournel S, Préville X. Fend L, et al. Among authors: foloppe j. Oncoimmunology. 2015 Oct 6;5(2):e1080414. doi: 10.1080/2162402X.2015.1080414. eCollection 2016 Feb. Oncoimmunology. 2015. PMID: 27057460 Free PMC article.
Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus.
Myers R, Coviello C, Erbs P, Foloppe J, Rowe C, Kwan J, Crake C, Finn S, Jackson E, Balloul JM, Story C, Coussios C, Carlisle R. Myers R, et al. Among authors: foloppe j. Mol Ther. 2016 Sep;24(9):1627-33. doi: 10.1038/mt.2016.139. Epub 2016 Jul 4. Mol Ther. 2016. PMID: 27375160 Free PMC article.
Oncolytic properties of non-vaccinia poxviruses.
Ricordel M, Foloppe J, Pichon C, Findeli A, Tosch C, Cordier P, Cochin S, Quémeneur E, Camus-Bouclainville C, Bertagnoli S, Erbs P. Ricordel M, et al. Among authors: foloppe j. Oncotarget. 2018 Nov 13;9(89):35891-35906. doi: 10.18632/oncotarget.26288. eCollection 2018 Nov 13. Oncotarget. 2018. PMID: 30542506 Free PMC article.
By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P, Remy-Ziller C, Winter E, Gantzer M, Nourtier V, Kempf J, Hortelano J, Schmitt D, Schultz H, Geist M, Brua C, Hoffmann C, Schlesinger Y, Villeval D, Thioudellet C, Erbs P, Foloppe J, Silvestre N, Fend L, Quemeneur E, Marchand JB. Kleinpeter P, et al. Among authors: foloppe j. J Virol. 2019 May 15;93(11):e00207-19. doi: 10.1128/JVI.00207-19. Print 2019 Jun 1. J Virol. 2019. PMID: 30918073 Free PMC article.
23 results